Grey Zone Lymphoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT02623920) | University of Arizona | 2015-12-16 |
Track Grey Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.